The Hospital of the University of Munich, Germany, is one of the largest and most competitive university hospitals in Germany and Europe.The Division of Clinical Pharmacology at Ludwig-Maximilians-Universität in Munich invites applications for one research position within the European Innovation Training Network IMMUTRAIN: Immunotherapy of Cancer.
Early Stage Researcher (PhD Students) (male/female) – ESR 1
Description of the project: Adoptive T cell transfer for cancer therapy
Combination of antibodies with adoptive T cell transfer. It will comprise: Genetic engineering of T-cells for enhanced functionality against cancer- Validation in different animal models – Function analysis and description of cellular product.
Early Stage Researcher (PhD Students) (male/female) – ESR 13
Description of the project: Tumor-Targeting of Therapeutic Nucleic Acids for the Immunotherapy of Cancer
Combination of antibodies with therapeutic nucleic acids. It combines therapeutic nucleic acids and antibodies in a novel carrier system to target the tumor microenvironment, thereby stimulating the immune system to recognize and eradicate tumor cells.
Website for application: http://portal.graduatecenter-lmu.de/ocgc/itn-immutrain
Application deadline: August 5th 2016